 Inhibitor thrombin time systemic amyloidosis common coagulation abnormality Patients primary systemic amyloidosis AL experience bleeding coagulation abnormality AL patients primary systemic AL years prolongation thrombin time range seconds normal seconds reptilase time range seconds normal seconds fibrinogen plasma patients beta-alanine concentration mg/dL thrombin times precipitated fibrinogens normal patients inhibitor responsible abnormal tests addition patient fibrinogen-free plasma normal plasma thrombin times result presence inhibitor inhibitor likely present patients nephrotic syndrome patients congestive heart failure monoclonal protein patients presence amyloid liver involvement presence amyloid neuropathy factors patient deficiency factor inhibition fibrinogen conversion fibrin clot dysfibrinogenemia cause prolonged thrombin time primary systemic AL